Weaning oxygen in infants with bronchopulmonary dysplasia
Crown Copyright © 2020. Published by Elsevier Ltd. All rights reserved..
Bronchopulmonary dysplasia (BPD) is a form of chronic lung disease commonly seen in preterm infants as the sequelae following respiratory distress syndrome. The management of evolving BPD aims to minimise lung injury and prevent the impact of hypoxia and hyperoxia. Proposed morbidities include respiratory instability, pulmonary hypertension, suboptimal growth, altered cerebral oxygenation and long-term neurodevelopmental impairment. The ongoing management and associated morbidity present a significant burden for carers and healthcare systems. Long-term oxygen therapy may be required for variable duration, though there is a lack of consensus and wide variation in practise when weaning supplemental oxygen. Furthermore, a shift in care towards earlier discharge and community care underlines the importance of a structured discharge and weaning process that eliminates the potential risks associated with hypoxia and hyperoxia. This review article describes recent evidence outlining oxygen saturation reference ranges in young infants, on which structured guidance can be based.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:39 |
|---|---|
| Enthalten in: |
Paediatric respiratory reviews - 39(2021) vom: 01. Sept., Seite 82-89 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Everitt, Lucy H [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bronchopulmonary dysplasia |
|---|
| Anmerkungen: |
Date Completed 28.10.2021 Date Revised 28.10.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.prrv.2020.10.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM318745178 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM318745178 | ||
| 003 | DE-627 | ||
| 005 | 20231225170008.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.prrv.2020.10.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1062.xml |
| 035 | |a (DE-627)NLM318745178 | ||
| 035 | |a (NLM)33309219 | ||
| 035 | |a (PII)S1526-0542(20)30143-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Everitt, Lucy H |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Weaning oxygen in infants with bronchopulmonary dysplasia |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.10.2021 | ||
| 500 | |a Date Revised 28.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Crown Copyright © 2020. Published by Elsevier Ltd. All rights reserved. | ||
| 520 | |a Bronchopulmonary dysplasia (BPD) is a form of chronic lung disease commonly seen in preterm infants as the sequelae following respiratory distress syndrome. The management of evolving BPD aims to minimise lung injury and prevent the impact of hypoxia and hyperoxia. Proposed morbidities include respiratory instability, pulmonary hypertension, suboptimal growth, altered cerebral oxygenation and long-term neurodevelopmental impairment. The ongoing management and associated morbidity present a significant burden for carers and healthcare systems. Long-term oxygen therapy may be required for variable duration, though there is a lack of consensus and wide variation in practise when weaning supplemental oxygen. Furthermore, a shift in care towards earlier discharge and community care underlines the importance of a structured discharge and weaning process that eliminates the potential risks associated with hypoxia and hyperoxia. This review article describes recent evidence outlining oxygen saturation reference ranges in young infants, on which structured guidance can be based | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Bronchopulmonary dysplasia | |
| 650 | 4 | |a Oximetry | |
| 650 | 4 | |a Oxygen | |
| 650 | 4 | |a Preterm infant | |
| 650 | 4 | |a Saturations | |
| 650 | 4 | |a Sleep study | |
| 650 | 7 | |a Oxygen |2 NLM | |
| 650 | 7 | |a S88TT14065 |2 NLM | |
| 700 | 1 | |a Awoseyila, Adejumoke |e verfasserin |4 aut | |
| 700 | 1 | |a Bhatt, Jayesh M |e verfasserin |4 aut | |
| 700 | 1 | |a Johnson, Mark J |e verfasserin |4 aut | |
| 700 | 1 | |a Vollmer, Brigitte |e verfasserin |4 aut | |
| 700 | 1 | |a Evans, Hazel J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Paediatric respiratory reviews |d 2000 |g 39(2021) vom: 01. Sept., Seite 82-89 |w (DE-627)NLM119261928 |x 1526-0550 |7 nnns |
| 773 | 1 | 8 | |g volume:39 |g year:2021 |g day:01 |g month:09 |g pages:82-89 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.prrv.2020.10.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 39 |j 2021 |b 01 |c 09 |h 82-89 | ||